Literature DB >> 27118144

Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare.

Pricivel Carrera1, Maarten J IJzerman1.   

Abstract

Entities:  

Keywords:  Multiple criteria decision analysis; cost-effectiveness; drug reimbursement; health technology assessment; personalized health care; value-based pricing

Mesh：

Substances：

Year:  2016        PMID： 27118144     DOI： 10.1080/14737167.2016.1180980

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN： 1473-7167            Impact factor:   2.217


× No keyword cloud information.
  6 in total

Review 1.  New Models for the Evaluation of Specialized Medicinal Products: Beyond Conventional Health Technology Assessment and Pricing.

Authors:  Luca Pani; Karin Becker
Journal:  Clin Drug Investig       Date:  2021-05-20       Impact factor: 2.859

Review 2.  Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Authors:  Praveen Thokala; Jessica Ochalek; Ashley A Leech; Thaison Tong
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

Review 3.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123

4.  Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.

Authors:  Gabrielle Bertier; Jian Carrot-Zhang; Vassilis Ragoussis; Yann Joly
Journal:  Genome Med       Date:  2016-10-24       Impact factor: 11.117

Review 5.  Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature.

Authors:  Maarten J IJzerman; Hendrik Koffijberg; Elisabeth Fenwick; Murray Krahn
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

6.  Current landscape of personalized medicine adoption and implementation in Southeast Asia.

Authors:  Huey Yi Chong; Pascale A Allotey; Nathorn Chaiyakunapruk
Journal:  BMC Med Genomics       Date:  2018-10-26       Impact factor: 3.063
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.